In patients with type 1 diabetes mellitus (DM), a high plasma CTGF level is closely associated with mortality from end-stage renal disease associated with DN11, and urinary CTGF excretion is strongly linked to DN severity12. This evidence concerns the gene CCN2 and liver dysplastic nodule.